On this page
Qivigy
Immune Globulin Intravenous, Human-kthm, 10% Solution
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Qivigy
Proper name
Immune Globulin Intravenous, Human-kthm, 10% Solution
Licence type
351(a)
BLA number
125822
Applicant
Kedrion, S.p.A.
Center
CBER
Presentations
2
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 10G/100ML | Solution | Intravenous | Single-Dose Vial | Rx | September 26, 2025 |
| 5G/50ML | Solution | Intravenous | Single-Dose Vial | Rx | September 26, 2025 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |